Nov 23, 2020
Part 2 of the conversation with Francisco Gonzalez-Lima. We are talking about Methylene Blue as a potential therapy for Alzheimer’s. This is something that you can access yourself with the proper research needed to obtain a pharmaceutical grade. We talk about its potential as a therapy for early intervention...
Nov 10, 2020
This is a super technical episode. The guest is a world leader in brain energy and its impact on cognition and cognitive change that leads to Alzheimer’s. We had to break this episode into two parts.
The difference between early-onset Alzheimer’s (which is usually genetic) and late-onset Alzheimer’s that usually...
Oct 19, 2020
Dr. Dale Bredesen is a neuroscientist of the first order as well as a truly pioneering doctor in the fields of Alzheimer’s and Parkinson’s research. In 2014, Dr. Bredesen published a widely publicized case series of 10 people who improved from cognitive decline. He has gone on to teach thousands of practitioners...
Oct 5, 2020
The field of preventive neurology is coming. Detection of early brain damage is critical and our guest this episode, Darmiyan appears to have developed this technology.
This interview is with Darmiyan's co-founder, Kaveh Vejdani MD, currently serving as it's chief medical and technology officer.
A highly technical,...
Sep 21, 2020
In Feb 2018 Michele Mootz started the CrossFit Wellness Program focused on bringing CrossFit to populations that were not being addressed including those with serious chronic diseases as well as aging adults over 65 including those with cognitive impairment. We discuss the tremendous benefits they have seen to date. We...